 |
 |
|
 |
 |
Comments on Paper and Primary News |
 |
  |
| |
Primary News: Breaking Away: Human Glial Stem Cells Generate Neurons
Comment by: Kiminobu Sugaya
|
 |
 |
Submitted 19 March 2003
| Permalink
|
Posted 19 March 2003
|
 |
 |
This is a report to support neurogenesis in the adult human brain. Transplanted cells (Hoehn, 2002; Zung, 2003) and endogenous stem cells localized in the subventricular zone (Parent, 2002) are reported to migrate through white matter of the adult brain. The finding of neural progenitors in the white matter in the human brain reported in the current paper would be directly comparable to these findings in the rodent brains.
Since the authors of this paper found limited self-renewal ability of the white matter progenitor cells (WMPCs), these cells have left the stem cell lineage and become phenotypically committed progenitors. From this point of view of limited expandability, WMPCs from the adult human brain cell may not be a good candidate for transplantable materials for neuroreplacement therapies. Moreover, starting material may also be limited because the volume of biopsy sample and the population of the cells is small.
Rather, I think this article gives us a good rationale to treat patients with compounds that increase the progenitor cell population in the brain....
Read more
This is a report to support neurogenesis in the adult human brain. Transplanted cells (Hoehn, 2002; Zung, 2003) and endogenous stem cells localized in the subventricular zone (Parent, 2002) are reported to migrate through white matter of the adult brain. The finding of neural progenitors in the white matter in the human brain reported in the current paper would be directly comparable to these findings in the rodent brains.
Since the authors of this paper found limited self-renewal ability of the white matter progenitor cells (WMPCs), these cells have left the stem cell lineage and become phenotypically committed progenitors. From this point of view of limited expandability, WMPCs from the adult human brain cell may not be a good candidate for transplantable materials for neuroreplacement therapies. Moreover, starting material may also be limited because the volume of biopsy sample and the population of the cells is small.
Rather, I think this article gives us a good rationale to treat patients with compounds that increase the progenitor cell population in the brain. Although we need more detailed stem cell population studies during aging and under disease conditions, the human adult brain may have more effective self-repair systems than we thought.
View all comments by Kiminobu Sugaya
|
 |
 |
| |
Submit a Comment on this Paper |
 |
 |
 |
 |
| |
 |
 |
| |
REAGENTS/MATERIAL:
Xenografted rat brains sections were immunostained with III-tubulin–specific antibody TuJ1 (1:600; Covance), MAP2-specific antibody AP-20 (1:50; Sigma), HuC/HuD-specific mouse monoclonal antibody 16A11 (25 g/ml; H. Furneaux, Memorial Sloan-Kettering Cancer Center, New York), GAD67-specific rabbit antibody (1:100; Chemicon), GFAP-specific mouse antibody SMI 21 (1:1,000; Sternberger), GFAP-specific rabbit antibody (1:400; Sigma), CNP-specific mouse antibody SMI 91 (1:1000 Sternberger), human nestin–specific rabbit antibody (1:200; Chemicon), or doublecortin-specific rabbit antisera (1:100; C. Walsh, Harvard Medical School, Boston, Massachusetts).
For multiple-antigen labeling, antibodies against III-tubulin, MAP-2, GFAP and BrdU (BrdU-specific rat antibody; 1:200; Harlan, now carried by Immunologicals Direct) were incubated overnight at 4 °C. Fixed cultures were counterstained with DAPI (10 g/ml; Molecular Probes).
FUTURE DIRECTION:
As outlined by Kimonobu Sugaya in his comment, the stem cells isolated from the white matter are limited in their ability to double, suggesting that they may be of limited use for transplantation studies. However, the results are consistent with white matter neurogenesis and it would be interesting to determine if the such neurons are functional.
|
|
|
 |